MORISHITA JINTAN CO.,LTD.

4524

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-06FY2027 Q1

Revenue

128.2100M JPY

YoY +1.0%

Operating Income

4.2100M JPY

YoY +116.1%

Net Income

7.9100M JPY

YoY +69.7%

EPS

79.2JPY

YoY +98.7%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

127.7億円

95.7億円

63.8億円

31.9億円

Rev: 95.6億円Op: 3億円NI: 2.8億円

Rev: 113.6億円Op: 5.7億円NI: 4.9億円

Rev: 124.1億円Op: 7.2億円NI: 7億円

Rev: 127.7億円Op: 8億円NI: 5.5億円

Rev: 126.9億円Op: 6.9億円NI: 6.3億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income61.1%

Revenue Progress34.800M

Revenue Forecast12400M

Net Income Progress3.200M

Net Income Forecast5.300M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan